Transcription Factor Reprogramming for Homogeneous cDC1 Cell Yields
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating homogeneous populations of differentiated human myeloid/conventional DC type 1 (cDC1) cells in vitro are complex, require feeder layers, and result in low yields with mixed DC subsets.
Innovation Solution
The expression of transcription factors BATF3, IRF8, and PU.1 under specific promoters, along with additional transcription factors IRF7 and BATF, significantly improves the reprogramming efficiency of cells into cDC1s.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If current methods for generating human cDC1 cells are used, then cell differentiation can be achieved, but the process is complex, requires feeder layers, and results in low yields with mixed DC subsets
Solution Approach 1:
The patent extracts and identifies the specific transcription factors (BATF3, IRF8, PU.1) that are essential for cDC1 differentiation, separating them from the complex mixture of factors and feeder layer requirements in conventional protocols. This extraction allows for a simplified, direct reprogramming approach that eliminates unnecessary components while maintaining high yield and homogeneity.
Solution Approach 2:
The patent changes the parameter of transcription factor expression timing and combination, using a specific temporal profile and dosage of BATF3, IRF8, and PU.1 to achieve efficient cDC1 differentiation. This parameter optimization replaces the complex feeder layer system with a controlled molecular approach, improving both productivity and simplifying the protocol.
2Manufacturing precision
If forced expression of transcription factors is used to reprogram cells, then cell type conversion is achieved, but the process lacks precision and results in mixed populations
Solution Approach 1:
The patent applies local quality by specifying precise spatial and temporal expression patterns of transcription factors. Instead of uniform forced expression, it uses controlled, localized activation of specific factors (BATF3, IRF8, PU.1) at specific stages, achieving homogeneous cell populations while maintaining high reprogramming efficiency.
Solution Approach 2:
The patent incorporates feedback mechanisms through the use of inducible promoters and temporal control systems that monitor and adjust transcription factor expression based on cell state. This feedback loop ensures precise reprogramming and eliminates mixed populations while maintaining high efficiency.
Data Source
AI summary
The present invention relates to compositions comprising transcription factors under control of promoter regions, wherein said compositions can be used for reprogramming cells to type 1 conventional dendritic cells or antigen-presenting cells. The invention further relates to methods for reprogramming cells into type 1 conventional dendritic cells or antigen-presenting cells.